
Esmovin 40mg Injection
Marketer
Asvins Lifecare
Salt Composition
Esomeprazole (40mg)
Overview Esmovin 40mg Injection
Acid-reducing injection Esmovin 40mg lessens gastric acid secretion. It treats stomach and intestinal conditions stemming from excess acid, including acid reflux and related disorders. This intravenous medication also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's intravenously given by a healthcare provider only when deemed superior to oral administration by your physician. Dosage and treatment length are determined by your condition and response. Lifestyle modifications, such as frequent small meals and avoiding caffeine, spicy, and fatty foods, can enhance treatment efficacy. Common, generally mild, side effects include injection site reactions, nausea, headache, dizziness, gas, diarrhea, abdominal pain, and fundic gland polyps. Persistent or bothersome symptoms necessitate medical consultation. Discuss osteoporosis prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Esmovin 40mg Injection is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with prior PPI allergies, and those with osteoporosis. Pregnant or lactating individuals require physician consultation. Alcohol consumption should be avoided due to its acid-stimulating effect.
Uses of Esmovin 40mg Injection
Managing Gastroesophageal Reflux Disease (GERD)
Major Benefits of Esmovin 40mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Esmovin 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esmovin 40mg Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
How Esmovin 40mg Injection works:
The injectable formulation of Esmovin, at a 40mg dose, functions as a proton pump inhibitor, decreasing gastric acid production to alleviate symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Esmovin 40mg Injection with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Esmovin 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The administration of Esmovin 40mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esmovin 40mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Caution is advised when administering Esmovin 40mg Injection to individuals suffering from severe renal impairment; dosage modification may be necessary. Patients should seek medical guidance. Dosage alteration is unnecessary for those with mild to moderate kidney dysfunction.
LiverCAUTION
For individuals with severely impaired liver function, administering Esmovin 40mg Injection requires careful consideration and potential dosage modification. Patients with mild to moderate liver impairment do not necessitate a dosage alteration. Physician consultation is advised.
What if you forget to take Esmovin 40mg Injection :
Omitting a scheduled dose of Esmovin 40mg Injection warrants immediate physician consultation.
Facts to Know About Esmovin 40mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Classification | Benzimidazole sulfinyl compound |
| Potential for Dependence | None. |
| Type of Medication | Gastrointestinal system |
| Mechanism of Action | Gastric acid secretion blockers |
